Change in Dengue and Japanese Encephalitis Seroprevalence Rates in Sri Lanka

被引:30
作者
Jeewandara, Chandima [1 ,2 ]
Gomes, Laksiri [1 ]
Paranavitane, S. A. [1 ]
Tantirimudalige, Mihiri [1 ]
Panapitiya, Sumedha Sandaruwan [1 ]
Jayewardene, Amitha [2 ]
Fernando, Samitha [1 ]
Fernando, R. H. [1 ]
Prathapan, Shamini [1 ]
Ogg, Graham S. [3 ,4 ,5 ]
Malavige, Gathsaurie Neelika [1 ,3 ,4 ]
机构
[1] Univ Sri Jayawardenapura, Fac Med Sci, Dept Microbiol, Ctr Dengue Res, Nugegoda, Sri Lanka
[2] Univ Sri Jayawardanapura, Dept Family Med, Fac Med Sci, Nugegoda, Sri Lanka
[3] MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford NIHR Biomed Res Ctr, London W1N 4AL, England
[4] Univ Oxford, Oxford OX1 2JD, England
[5] Churchill Hosp, Dept Dermatol, Oxford OX3 7LJ, England
来源
PLOS ONE | 2015年 / 10卷 / 12期
基金
新加坡国家研究基金会;
关键词
CROSS-REACTIVITY; PHASE-III; VACCINE; VIRUS; IMMUNOGENICITY; ANTIBODIES; INFECTION; CHILDREN; POPULATION; BURDEN;
D O I
10.1371/journal.pone.0144799
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Sri Lanka has been affected by epidemics of dengue infections for many decades and the incidence and severity of dengue infections have been rising each year. Therefore, we investigated the age stratified seroprevalence of dengue infections in order to facilitate future dengue vaccine strategies. In addition, since the symptomatic dengue infections have increased during the past few decades, we also investigated the possible association with Japanese Encephalitis Virus (JEV) antibody seropositivity with symptomatic dengue in a community cohort in Sri Lanka. Methods 1689 healthy individuals who were attending a primary health care facility were recruited. Dengue and JEV antibody status was determined in all individuals and JEV vaccination status was recorded. Results 1152/1689 (68.2%) individuals were seropositive for dengue and only 133/1152 (11.5%) of them had been hospitalized to due to dengue. A significant and positive correlation was observed for dengue antibody seropositivity and age in children (Spearmans R = 0.84, p = 0.002) and in adults (Spearmans R = 0.96, p = 0.004). We observed a significant rise in the age stratified seroprevalence rates in children over a period of 12 years. For instance, in year 2003 the annual seroconversion rate was 1.5% per annum, which had risen to 3.79% per annum by 2014. We also found that both adults (p<0.001) and in children (p = 0.03) who were hospitalized due to dengue were more likely to be seropositive for JEV antibodies. However, 244 (91.4%) of adults who were seropositive for JEV had not had the JEV vaccine. Conclusions Dengue seroprevalence rates have risen significantly over the last 12 years in Sri Lanka, possibly due to increased transmission. As individuals who were hospitalized due to dengue were more likely to be seropositive for JEV, the possibility of cross-reactive assays and/or of JEV infection on immunity to the DENV and clinical disease severity should be further investigated.
引用
收藏
页数:12
相关论文
共 35 条
  • [1] Preexisting Japanese Encephalitis Virus Neutralizing Antibodies and Increased Symptomatic Dengue Illness in a School-Based Cohort in Thailand
    Anderson, Kathryn B.
    Gibbons, Robert V.
    Thomas, Stephen J.
    Rothman, Alan L.
    Nisalak, Ananda
    Berkelman, Ruth L.
    Libraty, Daniel H.
    Endy, Timothy P.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (10):
  • [2] [Anonymous], JAP ENC MANN MED OFF
  • [3] [Anonymous], 2011, COMPREHENSIVE GUIDEL
  • [4] [Anonymous], Q EP REP 1 QUAT
  • [5] [Anonymous], NAT IMM SUMM 2015
  • [6] The global distribution and burden of dengue
    Bhatt, Samir
    Gething, Peter W.
    Brady, Oliver J.
    Messina, Jane P.
    Farlow, Andrew W.
    Moyes, Catherine L.
    Drake, John M.
    Brownstein, John S.
    Hoen, Anne G.
    Sankoh, Osman
    Myers, Monica F.
    George, Dylan B.
    Jaenisch, Thomas
    Wint, G. R. William
    Simmons, Cameron P.
    Scott, Thomas W.
    Farrar, Jeremy J.
    Hay, Simon I.
    [J]. NATURE, 2013, 496 (7446) : 504 - 507
  • [7] Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
    Capeding, Maria Rosario
    Ngoc Huu Tran
    Hadinegoro, Sri Rezeki S.
    Ismail, Hussain Imam H. J. Muhammad
    Chotpitayasunondh, Tawee
    Chua, Mary Noreen
    Chan Quang Luong
    Rusmil, Kusnandi
    Wirawan, Dewa Nyoman
    Nallusamy, Revathy
    Pitisuttithum, Punnee
    Thisyakorn, Usa
    Yoon, In-Kyu
    van der Vliet, Diane
    Langevin, Edith
    Laot, Thelma
    Hutagalung, Yanee
    Frago, Carina
    Boaz, Mark
    Wartel, T. Anh
    Tornieporth, Nadia G.
    Saville, Melanie
    Bouckenooghe, Alain
    [J]. LANCET, 2014, 384 (9951) : 1358 - 1365
  • [8] Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2-to 5-year-olds and Naive 12-to 24-month-olds Multicenter Randomized Controlled Trial
    Chokephaibulkit, Kulkanya
    Sirivichayakul, Chukiat
    Thisyakorn, Usa
    Sabchareon, Arunee
    Pancharoen, Chitsanu
    Bouckenooghe, Alain
    Gailhardou, Sophia
    Boaz, Mark
    Feroldi, Emmanuel
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (12) : 1111 - 1117
  • [9] Patterns of Flavivirus Seroprevalence in the Human Population of Northern Laos
    Conlan, James V.
    Vongxay, Khamphouth
    Khamlome, Boualam
    Jarman, Richard G.
    Gibbons, Robert V.
    Fenwick, Stanley G.
    Thompson, R. C. A.
    Blacksell, Stuart D.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (05) : 1010 - 1013
  • [10] Preexisting Neutralizing Antibody Responses Distinguish Clinically Inapparent and Apparent Dengue Virus Infections in a Sri Lankan Pediatric Cohort
    Corbett, Kizzmekia S.
    Katzelnick, Leah
    Tissera, Hasitha
    Amerasinghe, Ananda
    de Silva, Aruna Dharshan
    de Silva, Aravinda M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (04) : 590 - 599